Publikasi Scopus 2024 per tanggal 30 April 2024 (334 artikel)

Darmawan G.; Liman L.M.S.; Wibowo S.A.K.; Hamijoyo L.; Apriani L.; Atik N.; Alisjahbana B.; Sahiratmadja E.
Darmawan, Guntur (56418354100); Liman, Lie Monica Sherine (58298422800); Wibowo, Suryo Anggoro Kusumo (57477727300); Hamijoyo, Laniyati (25936059700); Apriani, Lika (35751908500); Atik, Nur (52063109800); Alisjahbana, Bachti (6506944516); Sahiratmadja, Edhyana (6506913121)
56418354100; 58298422800; 57477727300; 25936059700; 35751908500; 52063109800; 6506944516; 6506913121
Global tuberculosis disease and infection in systemic lupus erythematosus patients: A systematic review and meta-analysis
2024
Lupus
33
6
555
573
18
0
Doctoral Study Program, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Department of Internal Medicine, Faculty of Medicine, Krida Wacana Christian University, Jakarta, Indonesia; Bethel Medical Center, Jakarta, Indonesia; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Division of Infectious and Tropical Disease, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Research Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung, Indonesia
Darmawan G., Doctoral Study Program, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia, Department of Internal Medicine, Faculty of Medicine, Krida Wacana Christian University, Jakarta, Indonesia; Liman L.M.S., Bethel Medical Center, Jakarta, Indonesia; Wibowo S.A.K., Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Hamijoyo L., Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Apriani L., Department of Public Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Atik N., Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia; Alisjahbana B., Division of Infectious and Tropical Disease, Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia, Research Center for Care and Control of Infectious Disease, Universitas Padjadjaran, Bandung, Indonesia; Sahiratmadja E., Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia
Background: Tuberculosis (TB) is one of the most common infections among systemic lupus erythematosus (SLE) patients. We aimed to evaluate the global prevalence of TB infection and disease, its type, and medication risk factors in SLE patients. Methods: We searched PubMed, Science Direct, EBSCO, and Web of Science databases from inception to April 30, 2023, and included studies assessing TB among SLE patients. We estimated the prevalence of TB disease (including type of TB disease), TB infection, and SLE medication as TB risk factors. Meta-analysis was performed using Stata 14.2 and Review Manager 5.3. Results: Twenty-seven studies met the eligibility criteria. The global prevalence of TB disease was 4% (95% confidence interval (CI): 3–4%, n = 25) and TB infection was 18% (95% CI: 10–26%, n = 3). The pooled prevalence of pulmonary TB, extrapulmonary TB, and disseminated TB were 2% (95% CI: 2–3%, n = 20), 1% (95% CI: 1–2%, n = 17), and 1% (95% CI: 0–1%, n = 6), respectively. The 1-year cumulative glucocorticoid (GC) dose in SLE patients contracting TB was higher than in those without TB, having a mean difference of 2.56 (95% CI: 0.22–4.91, p <.00001, n = 3). The odd ratio of TB was 2.11 (95% CI: 1.01–4.41, p =.05, n = 3) in SLE patients receiving methylprednisolone (MP) pulse therapy as compared to those without MP pulse therapy. Other immunosuppressive agents were not significantly associated with TB. Conclusion: TB prevalence in SLE was relatively high and associated with GC. Awareness of TB and lowering GC dose are warranted to alleviate the TB burden in SLE. © The Author(s) 2024.
glucocorticoid; meta-analysis; systemic lupus erythematosus; Tuberculosis
Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Risk Factors; Tuberculosis; azathioprine; cyclophosphamide; cyclosporine; glucocorticoid; hydroxychloroquine; immunosuppressive agent; methotrexate; methylprednisolone; mycophenolate mofetil; glucocorticoid; immunosuppressive agent; adult; Article; corticosteroid therapy; drug pulse therapy; extrapulmonary tuberculosis; human; immunosuppressive treatment; lung tuberculosis; meta analysis; miliary tuberculosis; prevalence; risk factor; systematic review; systemic lupus erythematosus; tuberculosis; complication; risk factor; systemic lupus erythematosus; tuberculosis
Universitas Padjadjaran Internal Research Fund
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by Universitas Padjadjaran Internal Research Fund.
SAGE Publications Ltd
09612033
38490946
Article
Q2
822
5738